Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal erosion by a PDA occluder device following MAPC closure in tetralogy of Fallot.

Oxford medical case reports·2026
Same author

Tubo-ovarian abscess as an initial presentation of varicella in 12 years old child; a case report.

Oxford medical case reports·2025
Same author

Reassessing Antiplatelet Resistance in Ischemic Stroke: Addressing Key Gaps in Precision Medicine Research.

CNS neuroscience & therapeutics·2025
Same author

Calcium Sulfate as a Local Antibiotic Delivery Vehicle in Chronic Osteomyelitis Following Internal Fixation: A Prospective Case Series.

Reviews on recent clinical trials·2025
Same author

The implication of chlamydia and bacterial vaginosis among low-risk pregnant women with preterm birth: a prospective multicentric cohort study.

BMC pregnancy and childbirth·2025
Same author

Gut Microbiota Profile and Functional Gastrointestinal Disorders in Infants: A Longitudinal Study.

Nutrients·2025

Related Experiment Video

Updated: May 11, 2026

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
09:14

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

9.1K

Bridging Gaps in Long COVID Therapy: A Review.

Wassan Nori1, Zina Abdullah Hussein1, Roaa Mokram Hamed2

  • 1Department of Obstetrics and Gynecology, Al-Mustansiriya University, Baghdad, Iraq.

Current Medicinal Chemistry
|August 4, 2025
PubMed
Summary

Long COVID-19 (LC) affects 42% of individuals, presenting persistent symptoms. Therapeutic strategies show promise but require further validation and personalized approaches for improved patient outcomes.

Keywords:
Google scholarLong COVID-19SARS-CoV-2biomarkersnon-pharmacological optionspharmacological options

More Related Videos

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.0K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

884

Related Experiment Videos

Last Updated: May 11, 2026

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
09:14

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

9.1K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.0K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

884

Area of Science:

  • Medical Research
  • Public Health
  • Infectious Diseases

Background:

  • Long COVID-19 (LC) is a post-acute SARS-CoV-2 infection characterized by persistent fatigue, dyspnea, and cognitive impairment.
  • LC poses significant global health challenges, impacting patients' quality of life and functional capacity.
  • Pathophysiology, diagnosis, prevention, and treatment of LC remain areas with considerable inconsistencies and research gaps.

Purpose of the Study:

  • To review and address knowledge gaps in Long COVID-19 management.
  • To focus on therapeutic strategies, including non-pharmacological, pharmacological, experimental, and innovative approaches.
  • To evaluate the effectiveness of interventions and guide future research for improved patient outcomes.

Main Methods:

  • Comprehensive online literature search across PubMed, Scopus, Google Scholar, Web of Science, and Cochrane Library.
  • Utilized keywords: "long COVID," "pharmacological options," "non-pharmacological options," "innovative strategies," "experimental," and "quality of life (QOL)."
  • Extracted and synthesized data to categorize therapeutic approaches, critically analyzing their mechanisms, indications, outcomes, and limitations.

Main Results:

  • Pooled prevalence of Long COVID-19 was 42%, with symptom duration from 3 months to 2 years.
  • Key risk factors identified include female sex, unvaccinated status, and pre-existing comorbidities.
  • Diagnosis of LC is challenging due to a lack of standardized diagnostic criteria and reliable biomarkers.

Conclusions:

  • Non-pharmacological strategies demonstrated varied efficacy, though limited by small sample sizes in reported studies.
  • Pharmacological agents show potential but require further clinical validation.
  • Experimental and innovative therapeutic strategies necessitate longer-term studies and robust validation to confirm efficacy and safety.